Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Prevalence and clinical importance of mesenteric venous thrombosis in the Swiss Inflammatory Bowel Disease Cohort.

Vietti Violi N, Schoepfer AM, Fournier N, Guiu B, Bize P, Denys A; Swiss Inflammatory Bowel Disease Cohort Study Group.

AJR Am J Roentgenol. 2014 Jul;203(1):62-9. doi: 10.2214/AJR.13.12447.

PMID:
24951196
[PubMed - indexed for MEDLINE]
2.

Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients.

Pittet V, Rogler G, Mottet C, Froehlich F, Michetti P, de Saussure P, Burnand B, Vader JP; Swiss IBD Cohort Study Group.

Scand J Gastroenterol. 2014 Jun;49(6):662-73. doi: 10.3109/00365521.2014.896408. Epub 2014 Mar 12.

PMID:
24617517
[PubMed - in process]
3.

Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitis.

Maillard MH, Bortolotti M, Vader JP, Mottet C, Schoepfer A, Gonvers JJ, Burnand B, Froehlich F, Michetti P, Pittet V; Swiss IBD Cohort Study Group.

J Crohns Colitis. 2014 Aug 1;8(8):825-34. doi: 10.1016/j.crohns.2013.12.026. Epub 2014 Jan 22.

PMID:
24462322
[PubMed - in process]
4.

Coping is excellent in Swiss Children with inflammatory bowel disease: results from the Swiss IBD cohort study.

Rogler D, Fournier N, Pittet V, Bühr P, Heyland K, Friedt M, Koller R, Rueger V, Herzog D, Nydegger A, Schäppi M, Schibli S, Spalinger J, Rogler G, Braegger CP; Swiss IBD Cohort Study Group.

J Crohns Colitis. 2014 May 1;8(5):409-20. doi: 10.1016/j.crohns.2013.10.004. Epub 2013 Nov 12.

PMID:
24230970
[PubMed - in process]
5.

Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate.

Schoepfer AM, Dehlavi MA, Fournier N, Safroneeva E, Straumann A, Pittet V, Peyrin-Biroulet L, Michetti P, Rogler G, Vavricka SR; IBD Cohort Study Group.

Am J Gastroenterol. 2013 Nov;108(11):1744-53; quiz 1754. doi: 10.1038/ajg.2013.248. Epub 2013 Aug 27.

PMID:
23978953
[PubMed - indexed for MEDLINE]
6.

High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation.

Weiss GA, Troxler H, Klinke G, Rogler D, Braegger C, Hersberger M.

Lipids Health Dis. 2013 Jun 15;12:89. doi: 10.1186/1476-511X-12-89.

PMID:
23767972
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Penetrating or stricturing diseases are the major determinants of time to first and repeat resection surgery in Crohn's disease.

Pittet V, Rogler G, Michetti P, Fournier N, Vader JP, Schoepfer A, Mottet C, Burnand B, Froehlich F; Swiss Inflammatory Bowel Disease Cohort Study Group.

Digestion. 2013;87(3):212-21. doi: 10.1159/000350954. Epub 2013 May 23.

PMID:
23711401
[PubMed - indexed for MEDLINE]
8.

Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease: results from the Swiss Inflammatory Bowel Disease Cohort Study.

Sulz MC, Siebert U, Arvandi M, Gothe RM, Wurm J, von Känel R, Vavricka SR, Meyenberger C, Sagmeister M; Swiss IBD Cohort Study Group.

Eur J Gastroenterol Hepatol. 2013 Jul;25(7):790-7. doi: 10.1097/MEG.0b013e32836019b9.

PMID:
23571609
[PubMed - indexed for MEDLINE]
9.

Predictors of temporary and permanent work disability in patients with inflammatory bowel disease: results of the swiss inflammatory bowel disease cohort study.

Siebert U, Wurm J, Gothe RM, Arvandi M, Vavricka SR, von Känel R, Begré S, Sulz MC, Meyenberger C, Sagmeister M; Swiss IBD Cohort Study Group.

Inflamm Bowel Dis. 2013 Mar-Apr;19(4):847-55. doi: 10.1097/MIB.0b013e31827f278e.

PMID:
23446333
[PubMed - indexed for MEDLINE]
10.

Low prevalence of behavioural and emotional problems among Swiss paediatric patients with inflammatory bowel disease.

Herzog D, Landolt MA, Buehr P, Heyland K, Rogler D, Koller R, Rueger V, Pittet V, Nydegger A, Spalinger J, Schäppi M, Schibli S, Braegger CP; Swiss IBD Cohort Study Group.

Arch Dis Child. 2013 Jan;98(1):16-9. doi: 10.1136/archdischild-2012-302620. Epub 2012 Oct 19.

PMID:
23087189
[PubMed - indexed for MEDLINE]
11.

Tolerance and safety evaluation in a large cohort of healthy infants fed an innovative prebiotic formula: a randomized controlled trial.

Piemontese P, Giannì ML, Braegger CP, Chirico G, Grüber C, Riedler J, Arslanoglu S, van Stuijvenberg M, Boehm G, Jelinek J, Roggero P; MIPS 1 Working Group.

PLoS One. 2011;6(11):e28010. doi: 10.1371/journal.pone.0028010. Epub 2011 Nov 30.

PMID:
22140499
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease.

Eloranta JJ, Wenger C, Mwinyi J, Hiller C, Gubler C, Vavricka SR, Fried M, Kullak-Ublick GA; Swiss IBD Cohort Study Group.

Pharmacogenet Genomics. 2011 Sep;21(9):559-64. doi: 10.1097/FPC.0b013e328348f70c.

PMID:
21832969
[PubMed - indexed for MEDLINE]
13.

Epidemiology of inflammatory bowel disease: Is there a shift towards onset at a younger age?

Braegger CP, Ballabeni P, Rogler D, Vavricka SR, Friedt M, Pittet V; Swiss IBD Cohort Study Group.

J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):141-4. doi: 10.1097/MPG.0b013e318218be35.

PMID:
21788753
[PubMed - indexed for MEDLINE]
14.

Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease.

Vavricka SR, Spigaglia SM, Rogler G, Pittet V, Michetti P, Felley C, Mottet C, Braegger CP, Rogler D, Straumann A, Bauerfeind P, Fried M, Schoepfer AM; Swiss IBD Cohort Study Group.

Inflamm Bowel Dis. 2012 Mar;18(3):496-505. doi: 10.1002/ibd.21719. Epub 2011 Apr 20.

PMID:
21509908
[PubMed - indexed for MEDLINE]
15.

Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals.

Voegtlin M, Vavricka SR, Schoepfer AM, Straumann A, Voegtlin J, Rogler G, Ballabeni P, Pittet V, Buser A, Fried M, Beglinger C; Swiss IBD Cohort Study.

J Crohns Colitis. 2010 Dec;4(6):642-8. doi: 10.1016/j.crohns.2010.07.008. Epub 2010 Aug 12.

PMID:
21122574
[PubMed - indexed for MEDLINE]
16.

Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriateness.

Juillerat P, Pittet V, Vader JP, Burnand B, Gonvers JJ, de Saussure P, Mottet C, Seibold F, Rogler G, Sagmeister M, Felley C, Michetti P, Froehlich F; Swiss IBD Cohort Study Group.

Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1352-7. Erratum in: Eur J Gastroenterol Hepatol. 2011 Mar;23(3):294. Tempia-Caliera, Michela [corrected to Schäppi, Michela].

PMID:
20964261
[PubMed - indexed for MEDLINE]
17.

Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort.

Pittet V, Juillerat P, Michetti P, Vader JP, Burnand B, Rogler G, Beglinger C, Seibold F, Mottet C, Felley C, Gonvers JJ, Froehlich F; Swiss IBD Cohort Study Group.

Aliment Pharmacol Ther. 2010 Oct;32(8):1007-16. doi: 10.1111/j.1365-2036.2010.04434.x. Epub 2010 Aug 18.

PMID:
20937046
[PubMed - indexed for MEDLINE]
18.

Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants.

Grüber C, van Stuijvenberg M, Mosca F, Moro G, Chirico G, Braegger CP, Riedler J, Boehm G, Wahn U; MIPS 1 Working Group.

J Allergy Clin Immunol. 2010 Oct;126(4):791-7. doi: 10.1016/j.jaci.2010.07.022. Epub 2010 Sep 15.

PMID:
20832848
[PubMed - indexed for MEDLINE]
19.

Morphology of CaCo-2 cells varies in different cell batches.

Herold G, Rogler G, Rogler D, Stange EF.

In Vitro Cell Dev Biol Anim. 1994 May;30A(5):289-91. No abstract available.

PMID:
8069453
[PubMed - indexed for MEDLINE]
20.

Polyamine deficiency impairs proliferation and differentiation of cultured enterocytes (CaCo-2).

Herold G, Besemer F, Rogler D, Rogler G, Stange EF.

Z Gastroenterol. 1993 Feb;31(2):120-8.

PMID:
8465553
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk